Unveiling the Prospects of Precision Medicine in Future Kidney Disease Trials

Time: 5:00 pm
day: Conference Day 1


  • Reviewing progress in the development of predictive biomarkers of response to SGLT2s and ERAs to guide personalized treatment approaches for individual patients
  • Highlighting case studies of recent success to match specific CKD therapies to individual patients
  • Translating into clinical utility: how to deploy the tools developed primarily from cohort studies in a broader clinical trial setting